MOESM2 of Combining patient proteomics and in vitro cardiomyocyte phenotype testing to identify potential mediators of heart failure with preserved ejection fraction
posted on 2016-01-20, 05:00authored byRoseanne Raphael, Diana Purushotham, Courtney Gastonguay, Marla Chesnik, Wai-Meng Kwok, Hsiang-En Wu, Sanjiv Shah, Shama Mirza, Jennifer Strande
Additional file 2: Figure S2. Microscopy for Platelet Purity. Isolated platelets were observed under the microscope. Visible red blood cells and leukocytes were counted and calculated as a percentage of platelets in each field. Microscopy confirmation verified that the purified platelet had a leukocyte contamination < 0.02 % and a red blood cell contamination of < 1 %.
Funding
Clinical and Translational Science Award (CTSI) program of the National Center for Research Resources, National Institutes of Health